Nvidia’s latest 13F filing reveals that while the chipmaker’s portfolio saw a decline in the second quarter, many of its investments have shown gains for the year. As of the end of Q2, Nvidia held shares in Arm, SoundHound AI, Nano X Imaging, Recursion Pharmaceuticals, and Serve Robotics.
During the second quarter, most of these stocks experienced losses. Arm was the notable exception, rising approximately 30%, while SoundHound AI, Nano X Imaging, and Recursion Pharmaceuticals fell by 32%, 25%, and 32%, respectively. Serve Robotics, which began trading on the Nasdaq in April, saw its shares drop nearly 50% from its IPO price.
Despite the quarterly downturn, Nvidia’s portfolio has largely performed well year-to-date. Arm has surged 73%, SoundHound AI has more than doubled, and Nano X Imaging has gained 13%. Serve Robotics’ value has nearly tripled since its IPO. Conversely, Recursion Pharmaceuticals remains the only holding with a year-to-date decline, down nearly 32%.
Nvidia’s stake in Arm remains its most valuable, worth over $320 million at the end of June. The company’s filings reflect ongoing shifts in the tech investment landscape, with significant volatility but positive long-term trends for most of its holdings.
I’m a finance writer with three years of experience in investment analysis. At Investorwelcome , I translate complex financial concepts into clear, actionable insights to help investors navigate the market with confidence. Combining my solid academic background with practical industry knowledge, I’m dedicated to providing readers with accurate and timely information. My goal is to empower both new and seasoned investors by simplifying intricate data and offering strategic advice. When I’m not writing, I stay engaged with market trends and investment innovations to ensure my content remains relevant and valuable.
